Biofrontera (STU:AI10) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AI10 Biofrontera Inc STU:AI10
42 GF Score
Price €8.06
GF Value €3.90
! 7 Warning Signs
View Full Analysis

What is Biofrontera Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:AI10
42GF Score
Biofrontera Inc STU:AI10
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biofrontera (STU:AI10) Overvalued in 2026?

Based on GuruFocus' analysis, Biofrontera stock appears to be overvalued. The current stock price of €8.06 is trading 106.7% above its estimated GF Value™ of €3.90.

Key valuation signals for STU:AI10:

  • Interest Received:
  • GF Value™: €3.90 vs. price of €8.06 (106.7% above fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the STU:AI10 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biofrontera Business Description

Other Exchanges BFRI:USA
Address 660 Main Street, 1st Floor, Woburn, MA, USA, 01801
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
42GF Score

Get the complete analysis for STU:AI10

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.06
Price
€3.90
GF Value